News
04-09-2012, 10:00 AM
Sunshine Biopharma Inc. is pleased to announce that it has recently received notification that the United States Patent and Trademark Office has issued a "Notice of Allowance" for the patent application covering its lead anti-tumor compound, Adva-27a. The allowed claims protect Adva-27a and extensively cover various formulations, derivatives and cancer applications.
More... (http://www.news-medical.net/news/20120409/USPTO-issues-Notice-of-Allowance-for-Sunshine-Biopharmas-anti-tumor-compound-patent-application.aspx)
More... (http://www.news-medical.net/news/20120409/USPTO-issues-Notice-of-Allowance-for-Sunshine-Biopharmas-anti-tumor-compound-patent-application.aspx)